Detalles de la búsqueda
1.
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
Lancet
; 388(10060): 2607-2617, 2016 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806902
2.
Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial.
Catheter Cardiovasc Interv
; 85(3): E76-82, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25339110
3.
Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcome.
Catheter Cardiovasc Interv
; 85(1): 74-81, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24585502
4.
Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial.
Catheter Cardiovasc Interv
; 82(3): 396-405, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23359390
5.
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.
J Am Heart Assoc
; 7(3)2018 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29382666
6.
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.
Int J Cardiol
; 268: 11-17, 2018 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29801763
7.
"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
JACC Cardiovasc Interv
; 11(5): 448-459, 2018 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29454724
8.
5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.
JACC Cardiovasc Interv
; 11(5): 462-469, 2018 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29519378
9.
Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS.
J Cardiol
; 69(4): 660-665, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27476343
10.
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study.
EuroIntervention
; 11(13): 1487-94, 2016 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26465376
11.
Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial.
EuroIntervention
; 12(4): 431-40, 2016 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26342469
12.
Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials.
JACC Cardiovasc Interv
; 9(6): 553-61, 2016 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26947384
13.
Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial.
EuroIntervention
; 10(11): 1276-9, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25136888
14.
Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II).
JACC Cardiovasc Interv
; 8(7): 889-99, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26003019
15.
Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial.
EuroIntervention
; 10(6): 664-71, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25330500
16.
Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial.
J Am Coll Cardiol
; 61(24): 2406-2416, 2013 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23602769
17.
Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial).
Am J Cardiol
; 110(11): 1561-7, 2012 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22939581
18.
A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
J Am Coll Cardiol
; 59(15): 1350-61, 2012 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22341737
19.
How should I treat multiple coronary aneurysms with severe stenoses?
EuroIntervention
; 11(7): 843-6, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26603993
Resultados
1 -
19
de 19
1
Próxima >
>>